Nektar Therapeutics | Ventes





Ventes Changement Date
Agios Pharmaceuticals USD 19.97M 7.07M 2025-12
ALKERMES USD 384.5M 9.7M 2025-12
Alterity Therapeutics Limited AUD 11.38K 10.23K 2022-12
Amgen USD 9.9B 340M 2025-12
Baxter International USD 2.97B 130M 2025-12
BioCryst Pharmaceuticals USD -86.95M 204.03M 2024-12
Biogen USD 2.28B 250M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cipla INR 75.18B 710M 2025-12
Dr.Reddys Laboratories INR 87.27B 780M 2025-12
Eisai JPY 219.94B 22.58B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Exelixis USD 598.66M 860K 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Grifols EUR 2.34B 159.69M 2026-03
Halozyme Therapeutics USD 451.76M 97.76M 2025-12
Incyte USD 1.51B 140M 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
Ironwood Pharmaceuticals USD 47.71M 74.35M 2025-12
Karyopharm Therapeutics USD 30.54M 8.24M 2024-12
MacroGenics USD 72.84M 50.6M 2025-09
Merck USD 16.4B 880M 2025-12
Nektar Therapeutics USD 24.12M 635K 2024-09
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novartis USD 13.91B 144M 2025-09
Pfizer USD 17.58B 880M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Takeda JPY 1.19T 80B 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Xencor USD 28.24M 7.24M 2025-12


Nektar Therapeutics Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.